Evidence map›Paper›PMID 42564516›Full record

ArticleFrontiers in immunology2026

ClareV: a contrastive learning framework for context-aware TRBV representations in TCR repertoires.

Miaozhe Huo, Yu Cheng, Tongfei Shen, Jingwan Wang, Yuepeng Jiang

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miaozhe Huo *Department of Computer Science, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Yu Cheng *Department of Electrical and Computer Engineering, National University of Singapore, Singapore, Singapore.
Tongfei Shen *Department of Computer Science, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Jingwan WangDepartment of Computer Science, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Yuepeng JiangDepartment of Computer Science, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: V gene segments of the T cell receptor (TCR) Methods: We introduce ClareV, a contrastive learning framework that partitions T cell receptor repertoires into V gene-specific groups to extract data-driven embeddings capturing these dynamics. We evaluated ClareV across three TCR repertoire cohorts spanning cytomegalovirus (CMV), gastric cancer, and multi-cancer settings. Results: In the Emerson2017 CMV cohort, the ClareV Random Forest (RF) Fusion model improved AUC by 14.3% over the strongest V-family usage-only baseline (linear SVM) and by 13.3% over the strongest V-gene usage-only baseline (Random Forest). These results indicate that ClareV embeddings capture additional repertoire-level information beyond V-frequency summaries. Ablation studies showed that frequency-weighted bagging and contrastive V-bag learning both contributed to performance, outperforming simple pooling and non-contrastive learned-bag controls. In the CMV cohort, downstream embedding analyses showed that ClareV representations partially recapitulated IMGT-defined V-gene structure while retaining a CMV-responsive, non-sequence component that was largely orthogonal to classical V-usage signals. Discussion: These findings support adaptive V-gene representations as a compact feature space that complements V-frequency summaries for repertoire-level classification.

Indexed as

Receptors, Antigen, T-Cell, alpha-betaCytomegalovirusCytomegalovirus InfectionsHumansRandom ForestStomach NeoplasmsReceptors, Antigen, T-Cell, alpha-betacontext-aware embeddingscontrastive learningimmune memoryrepertoire classificationT cell receptor repertoireTRBV

Identifiers

PMID42564516
PMCPMC13443025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.